|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Seasonal abundance of parasitoids of the Mediterranean and oriental fruit fly in the Kula area of Matti, Hawaii显示文摘 | WONG T T Y MOCHIZUKI N NISHIMOTO J I | 1984 | Environmental Entomology1984，13，： | 1 |
| 2 | Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease显示文摘 | Nishimoto N Kanakura Y Aozasa K | 2005 | Blood2005，106，8： | 1 |
| 3 | lnterleukin-6 as a new indicator of inflammatory status:detection of serum levels of inteleukin-6 and e-reactive protein after surgery 显示文摘 | Ohzato H Yoshizaki K Nishimoto N | 1992 | Surgery1992，111，2： | 1 |
| 4 | Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy 显示文摘 | NISHIMOTO N SASAI M SHIMA Y | 2000 | Blood2000，95，1： | 1 |
| 5 | Human-ized anti-interleukin-6 receptor antibody treatment ofmulticentric Castleman disease显示文摘 | Nishimoto N Kanakura Y Aozasa K | 2005 | Blood2005，106，： | 1 |
| 6 | The paradigm of IL - 6 : from basis science to medicine 显示文摘 | Naka T Nishimoto N Kishimoto T | 2002 | Arthritis Res2002，4，3： | 1 |
| 7 | Study of active controlled monotherapy used for rhemnatoid arthritis, an ILa5 in- hibitor (SAMURAI) : evidence of clinical and radiographic bene- fit from an X ray reader-bfinded randomised controlled trial of to- cilizumab 显示文摘 | Nishimoto N Hashimoto J Miyasaka N | 2007 | Ann Rheum Dis2007，66，9： | 1 |
| 8 | Clinical studies in patients with Castleman's disease,Crohn's disease,and rheumatoid arthritis in Japan显示文摘 | NISHIMOTO N | 2005 | Clin Rev Allergy Immunol2005，28，3： | 1 |
| 9 | An analysis of 5-fluorouracil and cisplatin against advanced gastric cancer显示文摘 | Kim R nishimoto N Inoue H | 2000 | J Infect Chemother2000，6，4： | 1 |
| 10 | Suppressor of cytokine signaling-1 expression by infectivity-enhanced adenoviral vector inhibits IL-6-dependent proliferation of multiple myeloma cells显示文摘 | Yamamoto M Nishimoto N Davydova J | 2006 | Cancer Gene Therapy2006，13，2： | 1 |
| 11 | Interleukin-6 as a new indicator of inflammatiory status: Detection of surum levels of inter-leukin-6 and creactive protein after surgery 显示文摘 | LNAGAKI K YOSHIZAKI K NISHIMOTO N | 1992 | Surgery1992，111，： | 1 |
| 12 | Treatment of rheumationd arthritis with humanized anti- interleukin-6(IL-6) receptor antibody:a multicenter, double-blind, placebocontrolled trial 显示文摘 | Nishimoto N Yoshizaki K Miyasaka N | 2004 | Arthritis Rheum2004，50，： | 1 |
| 13 | Trends in incidence and prognosis for head and neck cancer in the United States:a site-specific analysis of the SEER database显示文摘 | CARVALHO A I NISHIMOTO I N CALIFANO J A | 2005 | Int J Cancer2005，114，： | 1 |
| 14 | 显示文摘 | Nishimoto A Agehara K Furuya N | 1999 | Macromolecules1999，32，： | 1 |
| 15 | Interleukin-6 as a therapeutic target in candi- date inflammatory diseases 显示文摘 | Nishimoto N | 2010 | Clin Pharma Therapeutics2010，87，： | 1 |
| 16 | Inhibition of IL-6 for the treatment of inflammatory diseases 显示文摘 | NISHIMOTO N KISHIMOTO T | 2004 | Curr Opin Pharmacol2004，4，4： | 1 |
| 17 | Long-term safety and efficacy of tocilizumab, an anti-lL-6 receptor monoclonal anti- body, in monotherapy, in patients with rheumatoid arthritis (the STREAM study) : evidence of safety and efl3cacy in a 5-year ex- tension study显示文摘 | Nishimoto N Miyasaka N Yamamoto K | 2009 | Ann Rheum Dis2009，68，10： | 1 |
| 18 | Distribution of aminoglycoside resistance genes in recent clinical isolates of Enterococcus faecalis, Enterococcus f aecium and Enterococcus avium显示文摘 | Kobayashi N Alam M Nishimoto Y | 2001 | Epidemiol Infect2001，126，2： | 1 |
| 19 | Serum hear-type fatty acid-binding protein concentration positively correlates with the length of aortic dissection显示文摘 | Hazui H Negoro N Nishimoto M | 2005 | Circulation Journal2005，69，8： | 1 |
| 20 | Clinical value of blocking IL-6 receptor显示文摘 | Mima T Nishimoto N | 2009 | Curr Opin Rheumatol?2009，21，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员